Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prakash

Showing results (311-320 of 339) with videos related to

Pageof 34
Sort By:
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Surgical Oncology|September 24, 2023
Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinomaArtem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Journal of the National Cancer Institute|May 11, 2026
Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium studyE M M Verkolf, J L van Dam, E N Dekker, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
JCO Precision Oncology|January 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic AdenocarcinomaAdriana C Gamboa, Kever A Lewis, Laura R Prakash, et al.
Journal of the National Cancer Institute|March 20, 2026
Restaging after neoadjuvant FOLFIRINOX for localized pancreatic cancer: a clinical calculator from the Trans-Atlantic Pancreatic Surgery consortiumEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 22, 2020
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinomaDongguang Wei, Mohamed M Zaid, Matthew H Katz, et al.
JAMA Surgery|September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System ParadigmArtem Boyev, Anish J Jain, Timothy E Newhook, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 13, 2017
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and PancreatoduodenectomyJordan M Cloyd, Graciela M Nogueras-González, Laura R Prakash, et al.
Journal of Surgical Oncology|August 16, 2021
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapyTimothy E Newhook, Laura R Prakash, Jose Soliz, et al.
Pageof 34

Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.
Surgical Oncology|September 24, 2023
Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinomaArtem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Journal of the National Cancer Institute|May 11, 2026
Prediction of resection after preoperative FOLFIRINOX in patients with localized pancreatic adenocarcinoma: a Trans-Atlantic Pancreatic Surgery (TAPS) Consortium studyE M M Verkolf, J L van Dam, E N Dekker, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
JCO Precision Oncology|January 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic AdenocarcinomaAdriana C Gamboa, Kever A Lewis, Laura R Prakash, et al.
Journal of the National Cancer Institute|March 20, 2026
Restaging after neoadjuvant FOLFIRINOX for localized pancreatic cancer: a clinical calculator from the Trans-Atlantic Pancreatic Surgery consortiumEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 22, 2020
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinomaDongguang Wei, Mohamed M Zaid, Matthew H Katz, et al.
JAMA Surgery|September 6, 2023
Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System ParadigmArtem Boyev, Anish J Jain, Timothy E Newhook, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 13, 2017
Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and PancreatoduodenectomyJordan M Cloyd, Graciela M Nogueras-González, Laura R Prakash, et al.
Journal of Surgical Oncology|August 16, 2021
Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapyTimothy E Newhook, Laura R Prakash, Jose Soliz, et al.
Pageof 34